Table 2 SAR studies and IC50s of compounds against human β5i and β5c

From: Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes

  1. All IC50s are means of at least three independent experiments, except that IC50s greater than 10 µM are means of two independent experiments
Back to article page